Semaglutide Cost: How Much Is It Per Month?
Medically reviewed by Dr. Kavya Patel, MD. Pricing is accurate as of August 2026 and subject to change.
Key Takeaways
- Wegovy lists at about $1,349/month; NovoCare's self-pay option runs $199/month for new patients, then $349/month ongoing.
- Compounded semaglutide at MaxLife starts at $100/month on the quarterly plan, the lowest legitimate route without insurance.
- Novo Nordisk will cut list prices to $675/month across Wegovy, Ozempic, and Rybelsus starting January 1, 2027, but that has not taken effect yet.
- Insurance coverage depends on diagnosis: near-universal for diabetes, uncommon for weight loss alone.
- Compounded medications are not FDA-approved and are not covered by insurance regardless of provider.
Semaglutide cost runs from roughly $1,349 a month at brand list price down to $100 a month for compounded semaglutide through a telehealth program. What you actually pay depends on which product you are buying, whether you have coverage, and where you source it.
Below you will find a full price comparison by route, what insurance actually changes, what MaxLife charges and what that includes, manufacturer savings programs, hidden fees to watch for, and the most realistic ways to bring the cost down.
Quick Answer: How Much Does Semaglutide Cost?
Here are the four scenarios most people fall into:
- Wegovy (brand-name): Lists at approximately $1,349 per month at retail pharmacies. Through Novo Nordisk's NovoCare Pharmacy, self-pay patients can access Wegovy injection starting at $199 a month for new patients' first two fills, then $349 a month for standard doses.
- Ozempic and Rybelsus (brand-name): Both list at approximately $1,027 per month. These are approved for type 2 diabetes, not weight loss.
- Compounded semaglutide: Typically a fraction of brand-name cost, with MaxLife starting at $100 a month on the quarterly plan.
- With insurance: Anywhere from about $25 a month with a savings card to several hundred dollars depending on your plan, formulary tier, and deductible.
There is no FDA-approved generic semaglutide, which is why brand prices stay elevated across all retail routes. Novo Nordisk has announced a list price reduction to $675 per month across Wegovy, Ozempic, and Rybelsus effective January 1, 2027, but those prices are not yet in effect.
Semaglutide Price Comparison Table
The table below puts the main routes side by side so you can see exactly where the differences come from.
| Option | Typical Monthly Cost | Insurance Required | What's Included |
|---|---|---|---|
| Wegovy (brand-name, retail pharmacy) | ~$1,349 | No (list price) | Medication only |
| Ozempic (brand-name, retail pharmacy) | ~$1,027 | No (list price) | Medication only |
| Rybelsus (brand-name, retail pharmacy) | ~$1,027 | No (list price) | Medication only |
| Compounded semaglutide (general market) | $200-$500 | No | Varies by provider |
| MaxLife compounded semaglutide | $100/mo | No | Medication, supplies, provider review, shipping |
The same active ingredient can cost more than eight times as much depending purely on the route you take. Someone paying Wegovy list price at a retail pharmacy faces over $16,000 a year. The MaxLife quarterly plan comes to $1,860 a year. What separates these options is not the molecule but the distribution model, what is bundled into the price, and whether you are carrying a brand-name markup.
How Much Are Semaglutide Injections Without Insurance?
Without insurance, three realistic paths exist for accessing semaglutide. The first is paying the full cash price for a brand-name product at a retail pharmacy. The second is using Novo Nordisk's direct pharmacy option or patient assistance program if you qualify. The third is compounded semaglutide through a telehealth provider, which is the lowest-cost legitimate route currently available. All three deliver the same active ingredient at significantly different monthly costs.
Wegovy List Price
Wegovy is the semaglutide product FDA-approved specifically for chronic weight management. Its wholesale acquisition cost is approximately $1,349 per month. Retail pharmacy cash prices are higher than this because pharmacies add markup above the wholesale cost. Based on GoodRx retail data, cash prices at major pharmacy chains run approximately $1,600 to $1,790 per month depending on dose, with the 0.5 mg starting dose running as high as $1,788.
Novo Nordisk also offers a direct self-pay option through its NovoCare Pharmacy at $199 a month for new patients on starting doses, then $349 a month for standard ongoing doses. Medicare, Medicaid, and Tricare beneficiaries can use this self-pay pricing rather than being excluded from it.
Prices are subject to change, verify current terms at novocare.com before relying on these figures.
Ozempic and Rybelsus List Prices
Ozempic and Rybelsus both list at approximately $1,027 per month at retail pharmacies. Retail pharmacy cash prices for Ozempic are higher than the wholesale list price. Based on GoodRx retail data, cash prices at major pharmacy chains typically run from approximately $1,200 to $1,500 per month depending on dose and pharmacy. Rybelsus is the oral tablet form of semaglutide rather than an injection, and the same active ingredient applies to both.
Both products are FDA-approved for type 2 diabetes, not for weight management. Using either for weight loss is off-label, and coverage consequences follow from that distinction. An insurer classifies a claim by the approved indication of the drug, not by the molecule it contains, so Ozempic and Rybelsus are far more likely to be covered when prescribed for diabetes than for weight.
Compounded Semaglutide Cost
Compounded semaglutide contains the same active ingredient as Wegovy but is prepared by a licensed compounding pharmacy rather than manufactured under a brand. Typical market pricing runs from roughly $200 to $500 a month, though the range varies by provider, dose, and what is bundled.
A few facts matter before committing. Compounded medications are not FDA-approved and are not covered by insurance. Semaglutide came off the FDA shortage list in February 2025, ending the exemption that had allowed 503B outsourcing facilities to compound it at scale. In April 2026, the FDA proposed formal restrictions on 503B bulk compounding. 503A pharmacies, which compound for individual patients with a valid prescription, operate under different rules, though this area is actively evolving. Verify the current status of your provider's pharmacy partners before committing.
This route only makes sense through a provider working with properly licensed 503A pharmacies in your state.
MaxLife names its partners, Hallandale Pharmacy, Red Rock Pharmacy, and Strive Pharmacy, which lets you verify them independently before signing up.
Does Insurance Cover Semaglutide?
The answer depends almost entirely on which product is prescribed and for what diagnosis. Coverage for weight loss is uncommon. Coverage for type 2 diabetes is near-universal across commercial insurance, Medicare Part D, and Medicaid. That single factor, the diagnosis on your prescription, determines which coverage rules apply and what you actually pay.
Why Weight Loss Coverage Is So Rare
Ozempic and Rybelsus are approved for type 2 diabetes. Prescribing them for weight management is off-label, and commercial insurance plans rarely pay for off-label prescriptions in a weight-loss context. Wegovy carries an FDA weight-management indication, which makes it eligible for coverage under plans that include it, but most employers treat anti-obesity medication as an optional benefit and exclude it from the plan they purchase.
The denial is almost always a plan-design decision, not a judgment about your medical case. Your employer chose not to include this benefit category when selecting the plan, and the insurer is applying that choice. Understanding this matters because it clarifies what the path forward requires: either the plan design changes, or you pay out of pocket, use a savings program, or choose a lower-cost route.
What You Might Pay With Insurance
When coverage does exist, costs depend on formulary tier, your deductible, and whether a manufacturer savings card applies. These ranges vary significantly by plan and are general estimates only:
- Commercial insurance with a savings card: As low as $25 a month when your plan covers the drug and your copay is within the card's savings cap.
- Low-deductible commercial plan without a savings card: Roughly $30 to $100 a month for a covered drug on a preferred formulary tier.
- High-deductible plan before the deductible is met: Potentially several hundred dollars a month, even when the drug is technically covered.
- Medicaid: A limited number of states cover Wegovy for obesity. Where approved, costs may be $0 or a few dollars. Medicaid coverage for Ozempic when prescribed for type 2 diabetes is near-universal across states.
- Medicare: Standard Part D does not cover semaglutide for weight loss. The Medicare GLP-1 Bridge program launched July 1, 2026 and covers Wegovy at a $50 monthly copay for eligible Part D enrollees through December 2027.
The only reliable answer about your specific plan comes from its formulary or from the member services number on the back of your card.
Semaglutide Cost Per Month at MaxLife
MaxLife offers compounded semaglutide at $100 a month on the quarterly plan. That comes to $360 for three months. On the quarterly plan, semaglutide starts at $100 a month. The monthly plan may have a different ongoing rate after the first month, so check current pricing at checkout.
Both plans include the medication, supplies, licensed provider review, ongoing support, and free overnight shipping. No insurance is required, there are no additional fees added at checkout, and no long-term contract is required. You can cancel with 30 days' notice before your next billing period begins. Plans are FSA and HSA eligible, which means you can pay with pre-tax dollars to reduce your effective monthly cost further.
The medication is prepared by named, licensed pharmacy partners: Hallandale Pharmacy, Red Rock Pharmacy, and Strive Pharmacy. Naming these partners allows you to verify them independently before committing, which is the transparency standard worth holding any compounding provider to.
Compared to the brand-name routes covered earlier, MaxLife's $100 monthly rate represents roughly 11 cents on the dollar of Wegovy's retail list price, and less than half the $349 a month standard self-pay rate through NovoCare Pharmacy.
Manufacturer Savings Programs
Two types of programs exist, and they work differently.
Novo Nordisk savings cards are available for both Wegovy and Ozempic, but they require commercial insurance that already covers the drug. On a 1-month fill, the savings cap is $100. On a 2-month fill, the cap is $200. On a 3-month fill, the cap is $300. When your copay falls within those savings caps, your out-of-pocket cost can be as low as $25. These programs are not available to anyone on Medicare, Medicaid, Tricare, VA, or other government-funded insurance, and they do not apply when the drug is not on your plan's formulary. Terms change; verify current terms at novocare.com before relying on these figures.
Patient assistance programs are separate from savings cards. Novo Nordisk's NovoCare assistance program can provide Ozempic or Rybelsus at no cost to qualifying patients who have type 2 diabetes, meet income criteria, and are uninsured or on Medicare. These programs are income-based and require an application. Wegovy's assistance program exists under separate criteria. Check eligibility directly at novocare.com.
Watch Out for Hidden Fees and Upfront Commitments
The advertised monthly price for semaglutide through a telehealth provider is often not the total you will actually pay. Some platforms add membership fees, consultation charges, lab work, or shipping costs on top of the medication price. Others require you to pay for five or six months upfront in full before you begin, which turns a $199 monthly headline into a commitment of over $1,000 before you know whether the medication suits you.
Before signing up with any provider, ask the following questions:
- Is the medication included in the monthly price, or billed separately?
- Are supplies such as syringes and alcohol wipes included?
- Is shipping included, or charged per shipment?
- Is there a separate membership or platform fee on top of the medication cost?
- Does the price rise after the first month or the first billing period?
- How many months must be paid upfront before starting?
- Is there a contract or a cancellation penalty?
At MaxLife, the medication and supplies are included in the plan price. Overnight shipping is free. There is no separate membership fee layered on top, and the quarterly plan runs three months rather than five or six. No long-term contract is required.
The only number worth comparing between providers is your total monthly cost with everything included. A low headline rate that excludes supplies and shipping can easily match or exceed a higher stated rate that bundles everything in.
How to Lower Your Semaglutide Cost
If standard pricing is out of reach, these are the most realistic legitimate ways to reduce what you pay:
- Manufacturer savings cards: Available for Wegovy and Ozempic if your commercial insurance plan covers the drug. These can bring your monthly cost down to as little as $25. Not available to Medicare, Medicaid, Tricare, or VA patients.
- Patient assistance programs: NovoCare's program can provide Ozempic or Rybelsus at no cost to qualifying uninsured or Medicare patients with type 2 diabetes and income eligibility.
- NovoCare direct pharmacy: Self-pay patients can access Wegovy through Novo Nordisk's NovoCare Pharmacy at $199 a month for new patients' first two fills, then $349 a month for standard injection doses, substantially below retail pharmacy list price.
- Prescription discount cards: Services such as GoodRx can reduce retail pharmacy costs, though savings vary significantly by location and participating pharmacy.
- 90-day or quarterly supplies: Paying for three months at a time rather than month by month typically lowers the effective monthly rate with most telehealth providers.
- Compounded semaglutide through a licensed 503A provider: Currently the lowest-cost legitimate route for patients without usable insurance coverage, provided you use a provider working with named, independently verifiable pharmacy partners in your state.
- HSA or FSA funds: Prescription medications are eligible medical expenses under both health savings accounts and flexible spending accounts, even when your insurance declines to cover the cost. Paying with pre-tax dollars reduces your effective monthly cost by your marginal tax rate before you compare any headline prices.
Only use telehealth providers with prescribers licensed in your state and pharmacy partners that are named and independently verifiable. Unlicensed or unverifiable compounding pharmacies carry real quality and safety risks that offset any apparent savings.
Cheaper Alternatives to Semaglutide
Not every patient can sustain the cost of a GLP-1 medication, and some readers searching semaglutide cost want to know what a provider might consider instead. Several oral medications are prescribed for weight management at a fraction of the monthly cost of injections.
Metformin is a generic diabetes medication sometimes used off-label for weight management and costs a few dollars a month at most pharmacies. Bupropion, naltrexone, and topiramate are also used off-label in various combinations. Contrave bundles bupropion and naltrexone in a single pill and carries FDA approval for chronic weight management. Qsymia combines phentermine and topiramate in an FDA-approved formulation.
None of these produce weight-loss outcomes comparable to semaglutide based on clinical data. That is the honest statement, and it should inform the comparison rather than settle it. The right medication is a clinical decision based on your health history, risk factors, and what outcomes you need to achieve. Cost is a legitimate secondary factor. This is a conversation to have with your prescriber, not a self-select decision based on price alone.
How Does Tirzepatide Cost Compare?
The comparison between semaglutide and tirzepatide on cost produces one counterintuitive result. Brand-name tirzepatide, sold as Zepbound for weight loss and Mounjaro for type 2 diabetes, lists at approximately $1,086 per month, which is actually below Wegovy's $1,349 list price despite tirzepatide producing higher average weight loss in clinical trials.
On the compounded side, the comparison goes the other direction. Compounded tirzepatide at MaxLife starts at $120 a month, compared to $100 a month for compounded semaglutide. Tirzepatide costs more on the compounded market because the active ingredient itself costs more to source.
The choice between the two should be a clinical one, based on your response, tolerance, and health history rather than price alone. Cost is a reasonable secondary factor once the clinical direction is clear.
Get Transparent Semaglutide Pricing
The only price that matters is your total monthly cost with everything included. Advertised rates that exclude shipping, supplies, or provider fees do not reflect what you will actually pay each month.
Checking eligibility through MaxLife takes minutes and requires no insurance or prior authorization. At MaxLife, compounded semaglutide starts at $100 a month on the quarterly plan, with medication, supplies, licensed provider review, and free overnight shipping included. Plans are FSA and HSA eligible. No long-term contract is required, and there are no additional fees to discover after you start.
Conclusion
Semaglutide cost spans from $100 a month to well over $1,300 depending entirely on the route. Wegovy lists at approximately $1,349 at retail pharmacies, with a self-pay option through NovoCare Pharmacy starting at $199 a month for new patients, then $349 a month for standard doses. Ozempic and Rybelsus list at approximately $1,027. Compounded semaglutide at MaxLife starts at $100 a month on the quarterly plan. There is no generic, so savings come from the compounded route, the NovoCare direct program, or manufacturer savings cards for commercially insured patients.
Coverage for weight loss is uncommon and almost always a plan-design decision rather than a medical one. Always compare total monthly cost including fees and upfront requirements, not the advertised headline price.
For a full overview of available GLP-1 weight loss programs, MaxLife covers both semaglutide and tirzepatide without requiring insurance or prior authorization.
Semaglutide Cost FAQs
How much does semaglutide cost per month without insurance?
Without insurance, semaglutide cost ranges from $100 a month for compounded semaglutide through a provider like MaxLife, to $199 a month (new patients, first two fills) or $349 a month (ongoing standard doses) through Novo Nordisk's NovoCare direct pharmacy for Wegovy injection, to approximately $1,027 to $1,349 at retail pharmacy list prices depending on which product you are buying. The compounded route is the lowest-cost legitimate option for uninsured patients.
Why is compounded semaglutide cheaper than Wegovy?
Compounded semaglutide is prepared by a licensed compounding pharmacy rather than manufactured and marketed at scale by Novo Nordisk. It contains the same active ingredient but bypasses the brand-name manufacturing, distribution, and marketing costs built into Wegovy's price. Compounded medications are not FDA-approved, and their quality depends on the specific pharmacy preparing them.
Is there a generic version of semaglutide?
No. There is no FDA-approved generic version of semaglutide. Novo Nordisk's patents remain in effect, which keeps brand-name list prices high and means no low-cost generic alternative exists at retail pharmacies. Novo Nordisk has announced a list price reduction to $675 per month across Wegovy, Ozempic, and Rybelsus effective January 1, 2027, but that change does not take effect until then.
Why does insurance cover Ozempic but not Wegovy?
Ozempic is FDA-approved for type 2 diabetes, and diabetes coverage is near-universal across commercial insurance, Medicare Part D, and Medicaid. Wegovy contains the same active ingredient at a higher dose but carries an FDA approval specifically for chronic weight management. Most employers treat anti-obesity medication as an excluded or optional benefit. The insurer applies the plan design your employer purchased. What determines coverage is the approved indication, not the molecule.
Can I use my HSA or FSA to pay for semaglutide?
In most cases, yes. Prescription medications are eligible expenses under both health savings accounts and flexible spending accounts, including compounded semaglutide prescribed for a qualifying condition. MaxLife plans are FSA and HSA eligible. Check with your plan administrator if you are uncertain whether your specific account covers compounded medications, and keep your prescription and receipts in case documentation is requested.
Does the price go up when I move to a higher dose?
For brand-name Wegovy pens, the list price is the same across all dose strengths. For compounded semaglutide through providers like MaxLife, dose changes may affect pricing depending on the specific plan. Ask your provider before escalating how any dose change will affect your monthly cost.
Skip the Wait. Check Your Eligibility With MaxLife
Compounded medications are not FDA-approved and are not covered by insurance. Pricing and availability are subject to change.
Check Your EligibilityThis article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Pricing, insurance coverage, and compounding regulations described here are subject to change; verify current details with your insurance provider, the manufacturer, or your prescriber before making treatment decisions. Compounded medications are not FDA-approved.
Sources
- Novo Nordisk: Press release, 2027 list price reduction for Wegovy, Ozempic, Rybelsus
- NovoCare Pharmacy: Self-pay pricing for Wegovy
- NovoCare: Savings card terms and patient assistance program eligibility
- FDA: Clarifies policies for compounders as national GLP-1 supply stabilizes
- CMS/Medicare: Medicare GLP-1 Bridge fact sheet
- GoodRx: Retail pharmacy pricing data
- FDA: Drugs@FDA database (approval status lookup)
